Harbor Capital Advisors »

Freeline Therapeutics Holdings shares owned by Harbor Capital Advisors

Quarter-by-quarter ownership of Freeline Therapeutics Holdings shares owned by Harbor Capital Advisors from 13F filings

Historical chart of Harbor Capital Advisors investment in Freeline Therapeutics Holdings

Tip: Access up to 7 years of quarterly data

All positions including Freeline Therapeutics Holdings held by Harbor Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Freeline Therapeutics Holdings by Harbor Capital Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $129k 20k 6.36
2023-09-30 $53k 13k 4.24
2023-06-30 $28k 11k 2.58

More positions owned by Harbor Capital Advisors

Microsoft Corporation (MSFT)
Consumer Discretionary SPDR (XLY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
Eli Lilly & Co. (LLY)
MasterCard Incorporated (MA)
Johnson & Johnson (JNJ)
Berkshire Hathaway (BRK.B)
Advanced Micro Devices (AMD)
Select Sector Spdr Tr Communic etfeqty (XLC)
Procter & Gamble Company (PG)
Dynatrace (DT)

View all positions for Harbor Capital Advisors

Top funds holding Freeline Therapeutics Holdings

UBS Group
Blue Owl Capital Holdings
PenderFund Capital Management
Harbor Capital Advisors
Sphera Funds Management

View all funds holding Freeline Therapeutics Holdings